Market research
6197.TSE Solasto Corporation
TSE JPY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 101B
- P/E ratio
- 27.4
- Analyst target
- 860
- Dividend yield
- 1.0%
- Beta
- 0.39
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- JP3436250009
- Market cap
- 101B
- P/E ratio
- 27.4
- Analyst target
- 860
- Dividend yield
- 1.0%
- Beta
- 0.39
About
About Solasto Corporation
Solasto Corporation provides medical outsourcing services to medical institutions in Japan. It operates through the Medical Business, Nursing Care Business, Children's Business, and Others segments. The Medical Business segment offers medical administration, medical affairs, and hospital management support services, as well as various surveys and analyses in the fields of medical administration and hospital management, document preparation, lectures and training, and educational courses on medical administration services. Its Nursing Care Business segment provides nursing care services, including nursing homes, residential nursing homes, and serviced housing for the elderly, as well as day care and home help services. The Children's Business segment offers childcare services, such as licensed, certified, and small-scale childcare centers, as well as childcare centers for recovering children. Its Others segment operates its smart hospital business that provides remote medical fee billing services to medical institutions. Solasto Corporation was formerly known as N.I.C Corporation. The company was founded in 1965 and is headquartered in Tokyo, Japan. As of May 11, 2026, Solasto Corporation operates as a subsidiary of MP-2605 Co., Ltd.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 6197.TSE discussion.
5 years, 5 months ago
Solasto Corporation is currently in a long term downtrend where the price is trading 2.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Solasto Corporation's total revenue rose by 13.9% to $28B since the same quarter in the previous year.
Its net income has increased by 10.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 33.0% to $3B since the same quarter in the previous year.
Based on the above factors, Solasto Corporation gets an overall score of 4/5.